Dialysis Pro vs Dialysis of Drugs Guide使用状況と統計

Dialysis Pro: Your Companion in Dialysis Health Tracking Manage your dialysis with ease and confidence using Dialysis Pro - the essential app for tracking and managing your dialysis journey. Dialysis Pro is designed to help you record key health metrics like fluid intake, weight, and blood pressure, so you're always equipped with the data you need to make informed decisions and share updates with your healthcare team. Dialysis Pro’s clean, user-friendly interface and powerful export capabilities make it easy to stay on top of your health and get the most out of your doctor visits. With options for ad-free and premium upgrades, Dialysis Pro lets you personalize your experience while keeping your data safe, private, and accessible whenever you need it. Key Features: Track important health metrics such as fluid intake, weight, and blood pressure Export data effortlessly for your next medical appointment Privacy-focused: health data is handled responsibly and not linked to your identity Free download with optional premium upgrades for enhanced features and an ad-free experience Download Dialysis Pro today and empower your dialysis journey with the support of streamlined, comprehensive health tracking! FEATURES * Track hemodialysis fluid loss/gain * Track peritoneal exchanges (APD/CAPD) * Get notifications for peritoneal treatment end (premium) * Track blood pressure * Track heart rate * Fluid tracking * Track weight * Track temperature * See your data over time via charts (premium) * Ability to export data as CSV ABOUT * Your data is kept on your device unless subscribed. Uninstalling will delete all your local data. * This app uses ads through the AdMob service. * This app uses Google Analytics. * Terms of Service ( https://cycosoft.com/d-track/terms ) * Dialysis Pro was previously known as D-Track

Apple App ストア
無料
医学

ストアランキング

- -

Dialysis of Drugs Guide

The guidelines contained in this application are designed to provide extensive, easy-to-read information regarding the dialyzability of drugs. Numerous literature sources have been used in preparing the guidelines. For many drugs, including newly-approved medications, investigational agents and medications available in other countries, there have been no dialysis pharmacokinetic studies. In some cases, the available data may conflict. Conditions of dialysis used in published studies may not reflect current dialysis practice and technology. Variations in the duration of dialysis, blood and dialysate flow rates, dialysis membranes, and whether peritoneal dialysis is continuous or intermittent, will all affect drug removal. These guidelines distinguish between conventional hemodialysis and high permeability (high-flux) hemodialysis where such data are available. No information is provided on drug dialyzability with continuous renal replacement therapy (CRRT) or with plasmapheresis. For additional information on specific drugs, the reader should consult the primary literature. Users of this application are referred to www.renalpharmacyconsultants.com for background and explanatory material to assist in the interpretation of the tabular data. The website provides specific information about factors that influence drug dialyzability and special considerations, such as CRRT, plasmapheresis and drugs of abuse. Users must be familiar with this information prior to using the content of this application. The website also includes a table presenting sieving coefficient data from in vitro and in vivo evaluations, which can be used to predict dosing requirements in CRRT, and a table regarding removal of drugs of abuse. The app requires a one year auto-renewing subscription to access application data. It will auto-renew unless you cancel the subscription, which you can do at any time. Terms of Service: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/